middle.news
Mayne Pharma surges as biotech setbacks drive the week’s biggest falls
11:31am on Saturday 21st of November, 2026 AEDT
•
MARKET NEWS
Read Story
Mayne Pharma surges as biotech setbacks drive the week’s biggest falls
11:31am on Saturday 21st of November, 2026 AEDT
Key Points
Mayne Pharma accepted a A$6.40-a-share cash offer from Gedeon Richter, valuing its equity at about A$604 million.
Actinogen shares fell 80% while trading was suspended ahead of Alzheimer’s trial results.
Argenica dropped 41.67% after the US FDA kept its stroke drug on clinical hold.
IDT rose 35.29% after forecasting FY27 revenue of A$19 million to A$20 million and positive EBITDA.
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
middle.news
OPEN ARTICLE